Health Care & Life Sciences » Pharmaceuticals | Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.58
Market Cap
$50.46 M
Shares Outstanding
51.1 M
Public Float
34.13 M

Profile

Address
80 Guest Street
Boston Massachusetts 02135
United States
Employees -
Website http://www.proteostasis.com
Updated 07/08/2019
Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W.

Financials

View All

Michael James Barrett
Chairman
Meenu Chhabra Karson
President, Chief Executive Officer & Director